Thus, elevated NfL levels may represent a surrogate biomarker for disease onset in A-ATTRv-related neuropathy in the absence of other possible aetiologies of neuropathy, as NfL may be elevated in other peripheral and central nervous system disorders. This evidence concerns the gene NEFL and central nervous system disorder.